Basics Terns Pharmaceuticals, Inc. IPO Date: February 1, 2021 Sector: Healthcare Industry: Biotech Market Cap: $262.89M Activated in VL: True Average Daily Range Avg Daily Range: $0.33 | 4.17% Avg Daily Range (30 D): $0.11 | 3.91% Avg Daily Range (90 D): $0.12 | 3.83% Institutional Daily Volume Avg Daily Volume: .52M Avg Daily Volume (30 D): .77M Avg Daily Volume (90 D): .94M Trade Size Avg Trade Size (Sh.): 112 Avg Trade Size (Sh.) (30 D): 122 Avg Trade Size (Sh.) (90 D): 120 Institutional Trades Total Inst.Trades: 477 Avg Inst. Trade: $1.83M Avg Inst. Trade (30 D): $.7M Avg Inst. Trade (90 D): $2.23M Avg Inst. Trade Volume: .25M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.75M Avg Closing Trade (30 D): $.95M Avg Closing Trade (90 D): $.91M Avg Closing Volume: 211.5K         News Sep 18, 2024 @ 2:07 PM This Small-Cap Stock Has a Promising GLP-1 Drug Wh... Source: David Jagielski Sep 15, 2024 @ 11:21 AM Missed Out on Viking Therapeutics? Buy This Weight... Source: Alex Carchidi Sep 15, 2024 @ 10:09 AM Should You Invest in This Under-the-Radar Weight L... Source: Prosper Junior Bakiny Sep 14, 2024 @ 2:12 PM 1 New Weight Loss Drug Stock to Buy Now With $1,00... Source: Alex Carchidi Sep 11, 2024 @ 2:50 AM Terns Announces Pricing of Upsized $150.15 Million... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.08 $-.26 $-.23 Diluted EPS $-1.08 $-.26 $-.23 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -90.39M $ -23.91M $ -21.8M Operating Income / Loss $ -103.85M $ -27.43M $ -25.95M Cost of Revenue $ $ $ Net Cash Flow $ 59.07M $ -22.42M $ -108.7M PE Ratio